What 8 Analyst Ratings Have To Say About Alpine Immune Sciences
Portfolio Pulse from Benzinga Insights
Alpine Immune Sciences (NASDAQ:ALPN) has received 8 bullish analyst ratings in the last quarter, with no bearish or indifferent ratings. The average 12-month price target for the company has increased by 32.14% from the previous average, now standing at $18.5 with a high of $22.00 and a low of $17.00.

October 18, 2023 | 9:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Alpine Immune Sciences has received positive analyst ratings, which could boost investor confidence and potentially drive the stock price up in the short term.
Analyst ratings often influence investor sentiment and can impact stock prices. In this case, Alpine Immune Sciences has received 8 bullish ratings and no bearish or indifferent ratings in the last quarter, which is a positive signal. Furthermore, the increase in the average 12-month price target suggests that analysts have a positive outlook on the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100